1 unknown, 1 withdrawn. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Unknown 1, Withdrawn 1 |
Follow Eczema: new trials by email Literature Review of Eczema trials Research Report on Eczema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glutamine Supplementation in People With Immune Dysregulation L-glutamine - Eczema, MTOROC1 Signaling | Early Phase 1 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-03-12 | 2020-03-16 | |
| Revitalization of Damaged Skin Due to Chronic Skin Diseases ACE CSD - Chronic Eczema, Psoriasis | Early Phase 1 | Unknown | Ace Cells Lab Limited | 200 | 2018-05-01 | 2018-04-02 |
Dermatitis, Atopic (1) · Psoriasis (1)
Dermatitis (2) · Skin Diseases (2) · Skin Diseases, Eczematous (2) · Skin and Connective Tissue Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Skin Diseases, Genetic (1) · Skin Diseases, Papulosquamous (1)
Glutamine (1)
Ace Cells Lab Limited (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Serbia (1) · United Kingdom (1) · United States (1)
Dr. Diana Diana, MSc Dermatology (1) · Joshua D Milner, M.D. (1)